Edition:
United Kingdom

People: Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

26.75HKD
16 Aug 2019
Change (% chg)

HK$0.60 (+2.29%)
Prev Close
HK$26.15
Open
HK$26.10
Day's High
HK$26.90
Day's Low
HK$25.70
Volume
5,607,582
Avg. Vol
6,194,213
52-wk High
HK$41.05
52-wk Low
HK$25.70

Chen, Qiyu 

Mr. Chen Qiyu is Non-Executive Vice Chairman of the Board of Sinopharm Group Co., Ltd., with effect from 22 September 2014. He joined the Company on 16 January 2003, and had served as the chief Supervisor until 31 May 2010. He has served as a non-executive Director since 31 May 2010 and has been the vice Chairman since November 2013. He has over 25 years of working experience. He obtained a bachelor’s degree in genetics from Fudan University in July 1993 and a master’s degree of business administration from China Europe International Business School in September 2005. Mr. Chen was previously the chief financial officer, the board secretary, general manager, president and vice chairman of the board of directors of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from July 1998 to May 2010, and has been its director and chairman since May 2005 and June 2010, respectively. He has served as the vice president and co-president of Fosun International Limited since August 2010, and has served as its executive director since July 2015. He has served as the vice president and co-president of Shanghai Fosun High Technology (Group) Co., Ltd. since January 2011, and has served as its director since July 2015 and has served as its Chairman since November 2017. Mr. Chen has been a director of Tianjin Pharmaceuticals Group Co., Ltd., Zhejiang DIAN Diagnostics Co., Ltd., and Beijing Sanyuan Food Co., Ltd. since February 2009, May 2010 and September 2015, respectively. Mr. Chen served as the supervisor, director as well as the director and general manager of Sinopharm Industrial Investment Co., Ltd from July 2008 to March 2014 successively, and has served as the vice chairman of the same since March 2014 till now. Mr. Chen is currently also the member of Shanghai 12th Committee of the Chinese People’s Political Consultative Conference, the chairman of China Medical Pharmaceutical Material Association and Shanghai Biopharmaceutics Industry Association.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Zhiming Li

6,572,000

Yong Liu

7,489,000

Qiyu Chen

--

Xiuchang Jiang

--

Maisong Cai

--

Jun Lu

--
As Of  31 Dec 2017